49. Systemic lupus erythematosus Clinical trials / Disease details


Clinical trials : 946 Drugs : 722 - (DrugBank : 186) / Drug target genes : 117 - Drug target pathways : 199

  
1 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT00960362
(ClinicalTrials.gov)
July 200914/8/2009An Investigation of AGS-009 in Patients With Systemic Lupus Erythematosus (SLE)A Randomised, Double-blind, Placebo-controlled, and Single Dose-escalation Trial of AGS-009 Administered in Subjects With Systemic Lupus ErythematosusInflammation;Systemic Lupus Erythematosus (SLE)Drug: AGS-009;Drug: placeboArgos TherapeuticsNULLCompleted18 Years65 YearsBoth13Phase 1United States;Sweden